title: Quantitative detection of thrombin activity in an ischemic stroke model.
abstract: Thrombin, a central factor in thrombogenesis, affects cells in the brain through protease activated receptors. Low levels of thrombin activity are neuroprotective while higher levels are deleterious, and we have therefore developed a new method for its direct quantitative measurement in brain slices following stroke. Thrombin activity was measured by a fluorescent substrate on fresh coronal slices taken from the ipsilateral and contralateral hemispheres 24-72 h following permanent right middle cerebral artery occlusion. Prolyl endopeptidase and aminopeptidases were inhibited as a critical step to insure the specificity of the assay for thrombin detection. Infarct volume was assessed using TTC staining. Thrombin activity in the right ischemic hemisphere was significantly higher compared to the contralateral hemisphere (32 ± 6 and 27 ± 10 mU/ml, mean ± SE in the two most affected slices from the ischemic hemisphere vs. 21 ± 6 and 8 ± 2 mU/ml in corresponding contralateral slices; p < 0.05). Thrombin levels in the ischemic and contralateral hemispheres were significantly higher compared to healthy control mice and were above the range known to be protective to brain cells. A significant correlation was found between thrombin activity in the ischemic hemisphere and the infarct volume. Results of studies based on this method may translate into potential thrombin based therapies.
authors.affiliation: Comprehensive Stroke Center, the Department of Neurology and Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel-Hashomer, Israel, doron.bushi@gmail.com.
authors.forename: Doron
authors.initials: D
authors.lastname: Bushi
authors.forename: Joab
authors.initials: J
authors.lastname: Chapman
authors.forename: Aviva
authors.initials: A
authors.lastname: Katzav
authors.forename: Efrat
authors.initials: E
authors.lastname: Shavit-Stein
authors.forename: Noa
authors.initials: N
authors.lastname: Molshatzki
authors.forename: Nicola
authors.initials: N
authors.lastname: Maggio
authors.forename: David
authors.initials: D
authors.lastname: Tanne
mesh_terms: D000818:Animals; D002540:Cerebral Cortex / Q000737:chemistry / Q000201:enzymology; D057075:Enzyme Assays / Q000379:methods*; D020244:Infarction, Middle Cerebral Artery / Q000201:enzymology*; D051379:Mice; D008810:Mice, Inbred C57BL; D009928:Organ Specificity; D013917:Thrombin / Q000032:analysis*
chemical_list: D013917:Thrombin
references.citation: J Neurochem. 2011 Nov;119(3):460-73
references.pmid: 21854391
references.citation: Ann N Y Acad Sci. 1986;485:335-48
references.pmid: 3032049
references.citation: Semin Thromb Hemost. 1996;22(3):267-71
references.pmid: 8836012
references.citation: J Neurosci. 2008 Jan 16;28(3):732-6
references.pmid: 18199772
references.citation: J Neurosci Res. 2006 Feb 15;83(3):469-75
references.pmid: 16397902
references.citation: Prog Brain Res. 2000;125:129-54
references.pmid: 11098654
references.citation: Stroke. 2002 Sep;33(9):2254-60
references.pmid: 12215596
references.citation: J Neurochem. 2003 Jan;84(1):3-9
references.pmid: 12485396
references.citation: Acta Neurochir Suppl. 2003;86:163-6
references.pmid: 14753426
references.citation: Stroke. 2004 Jul;35(7):1769-75
references.pmid: 15166395
references.citation: Brain Res. 1999 Jul 3;833(2):181-90
references.pmid: 10375693
references.citation: Neuroreport. 2001 Aug 8;12(11):2347-51
references.pmid: 11496108
references.citation: Stroke. 2010 Oct;41(10):2348-52
references.pmid: 20705928
references.citation: FASEB J. 2005 Mar;19(3):425-7
references.pmid: 15596484
references.citation: Stroke. 1999 Jun;30(6):1247-55
references.pmid: 10356108
references.citation: Stroke. 1989 Jan;20(1):84-91
references.pmid: 2643202
references.citation: Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2264-9
references.pmid: 10681455
references.citation: J Neurosci. 2012 May 30;32(22):7622-31
references.pmid: 22649241
references.citation: Trends Neurosci. 2000 Sep;23(9):399-407
references.pmid: 10941185
references.citation: J Neurosci. 1995 Apr;15(4):2906-19
references.pmid: 7722637
references.citation: Exp Neurol. 2013 Sep;247:595-604
references.pmid: 23454608
references.citation: Nature. 2000 Sep 14;407(6801):258-64
references.pmid: 11001069
references.citation: Brain Res. 2000 Jun 9;867(1-2):173-9
references.pmid: 10837811
references.citation: Eur J Biochem. 1988 Feb 15;172(1):17-25
references.pmid: 3278905
references.citation: Br J Pharmacol. 2012 Jan;165(1):106-19
references.pmid: 21564089
references.citation: J Stroke Cerebrovasc Dis. 2006 Jul-Aug;15(4):133-8
references.pmid: 17904065
references.citation: Nat Rev Neurosci. 2003 Dec;4(12):981-90
references.pmid: 14682360
references.citation: Stroke. 2001 Sep;32(9):2164-9
references.pmid: 11546912
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):13019-24
references.pmid: 14559973